NDC 63083-4023

Low Virus Nosode 4023

Low Virus Nosode

Low Virus Nosode 4023 is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Professional Complementary Health Formulas. The primary component is Bacillus Calmette-guerin Live Antigen, Unspecified Substrain; Coxsackievirus A21; Dalea Foliolosa Whole; Draba Verna Whole; Haemophilus Influenzae; Human Herpesvirus 4; Human Herpesvirus 5; Human Varicella-zoster Immune Globulin; Justicia Spicigera Leaf; Poliovirus Type 1 Antigen (formaldehyde Inactivated); Vaccinia Virus Strain New York City Board Of Health Live Antigen.

Product ID63083-4023_9bc902f0-449a-4d70-8146-c2d2a38dab14
NDC63083-4023
Product TypeHuman Otc Drug
Proprietary NameLow Virus Nosode 4023
Generic NameLow Virus Nosode
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date1984-08-15
Marketing CategoryUNAPPROVED HOMEOPATHIC /
Labeler NameProfessional Complementary Health Formulas
Substance NameBACILLUS CALMETTE-GUERIN LIVE ANTIGEN, UNSPECIFIED SUBSTRAIN; COXSACKIEVIRUS A21; DALEA FOLIOLOSA WHOLE; DRABA VERNA WHOLE; HAEMOPHILUS INFLUENZAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN; JUSTICIA SPICIGERA LEAF; POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN
Active Ingredient Strength30 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL
Pharm ClassesActively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Poliovirus Vaccine [EPC], Live Vaccinia Virus Vaccine [EPC], Poliovirus Vaccines [CS], Smallpox Vaccine [CS], Vaccines, Inactivated [CS], Vaccines, Live, Unattenuated [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 63083-4023-2

59 mL in 1 BOTTLE, DROPPER (63083-4023-2)
Marketing Start Date1985-08-15
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.